全球重組 C 因子檢測市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

預計到 2032 年，全球重組 C 因子檢測市場的市場規模將從 2023 年的 2,473 萬美元達到近 5,620 萬美元，2024-2032 年研究期間複合年成長率為 9.55%。

重組C因子測定用於測量內毒素暴露程度或熱原水準。它使用重組蛋白和小螢光肽（螃蟹裂解物的合成替代品）進行檢測。 rFC 具有三種不同的特異性：酶水平、光譜水平和基因水平，以便更好地將樣品中存在的雜質與其他不相關物質和雜質區分開。內毒素檢測在製藥業中發揮著至關重要的作用，因為它可確保注射藥品和醫療器材可供人類安全使用。這種測量技術的高靈敏度、特異性和較小的變異性可帶來更精確和準確的讀數。

市場動態

緩解鱟變形細胞裂解物 (LAL) 檢測需求不斷成長帶來的壓力的需求不斷成長，以及 rfC 等替代內毒素檢測測試的開發將成為該市場成長的趨勢因素。這些檢測方法的高精度、特異性、穩健性、永續性、批次一致性、易用性和適當的靈敏度範圍、增強的內毒素特異性和可重複性將擴大化妝品、研究、環境等多個產業的市場、食品和水質控制。鱟數量的減少及其滅絕的威脅將進一步推動該市場的成長。此市場發展的主要限制因素是與傳統方法相比射頻C缺乏功效。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球重組因子 C 檢測市場的各個細分市場進行了包容性評估。重組 C 因子檢測產業的成長和趨勢為本研究提供了整體方法。

市場區隔

重組因子 C 檢測市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按品牌

• PyroGene（PyroGene Bulk rFC（2,880 次測試）、PyroGene rFC（192 次測試））
• EndoNext（EndoZyme II、EndoZyme II GO、EndoLisa）

按最終用戶

• 製藥公司
• 生技公司
• 醫療器材公司
• 合約研究組織 (CRO)

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲重組 C 因子檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。重組 C 因子檢測市場的主要參與者包括 Lonza Group、Hyglos GmbH - BioMeRieux Company。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：重組因子分析 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按品牌分類的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球重整因子 C 檢測市場分析：按品牌

• 按品牌概覽
• 按品牌歷史和預測數據分析
• PyroGene（PyroGene Bulk rFC（2,880 次測試）、PyroGene rFC（192 次測試））
• EndoNext（EndoZyme II、EndoZyme II GO、EndoLisa）

第 6 章：全球重組因子 C 檢測市場分析：依最終用戶分類

• 最終用戶概述
• 最終用戶的歷史和預測數據分析
• 製藥公司
• 生技公司
• 醫療器材公司
• 合約研究組織 (CRO)

第 7 章：全球重組因子分析市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 8 章：重組因子 C 偵測公司的競爭格局

• 重組C因子檢測市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 9 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Lonza Group
• 公司概況
• 公司收入
• 產品
• 最新動態
• Hyglos GmbH - A BioMeRieux Company
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Recombinant Factor C Assay Market is presumed to reach the market size of nearly USD 56.2 Million by 2032 from USD 24.73 Million in 2023 with a CAGR of 9.55% under the study period 2024-2032.

Recombinant factor C assay is used to measure the scale of endotoxin exposure or level of pyrogens. It uses a recombinant protein and a small fluorescent peptide, a synthetic alternative to crab lysate, for detection. There are three different specificities of rFC, Enzymatic, Spectral, and Genetic level to better distinguish the impurity present in the sample from other, non-related substances and impurities. Endotoxin testing plays a critical role in the pharmaceutical industry since it ensures that injectable pharmaceutical products and medical devices are safe for human use. The high sensitivity, specificity, and lesser variability of this measurement technique lead to more precise and accurate readings.

MARKET DYNAMICS

The rising need to alleviate the pressures of a growing demand for the Limulus amoebocyte lysate (LAL) assay and the development of alternative endotoxin detection tests like rfC will be the trending factors for the growth of this market. The high accuracy, specificity, robustness, sustainability, lot-to-lot consistency, ease-of-use & a suitable sensitivity range, enhanced endotoxin specificity, and reproducibility of these assays will expand the market across several industries like cosmetics, research, environment, food, and water quality control. The decline in the horseshoe crab population and the threat of their extinction will further propel this market's growth. The main restraining factor for this market's development is the lack of efficacy of rfC compared to traditional methods.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Recombinant Factor C Assay. The growth and trends of Recombinant Factor C Assay industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Recombinant Factor C Assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Brand

• PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests))
• EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa)

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Contract Research Organizations (CROs)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Factor C Assay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Factor C Assay market include Lonza Group, Hyglos GmbH - A BioMeRieux Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. RECOMBINANT FACTOR C ASSAY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Brand
  • 3.7.2 Market Attractiveness Analysis By End User
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET ANALYSIS BY BRAND

• 5.1. Overview By Brand
• 5.2. Historical and Forecast Data Analysis By Brand
• 5.3. PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests)) Historic and Forecast Sales By Regions
• 5.4. EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa) Historic and Forecast Sales By Regions

6. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET ANALYSIS BY END USER

• 6.1. Overview By End User
• 6.2. Historical and Forecast Data Analysis By End User
• 6.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
• 6.4. Biotechnology Companies Historic and Forecast Sales By Regions
• 6.5. Medical Device Companies Historic and Forecast Sales By Regions
• 6.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions

7. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RECOMBINANT FACTOR C ASSAY COMPANIES

• 8.1. Recombinant Factor C Assay Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF RECOMBINANT FACTOR C ASSAY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Lonza Group
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Hyglos GmbH - A BioMeRieux Company
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Brand (USD MN)
• PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests)) Market Sales By Geography (USD MN)
• EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa) Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Biotechnology Companies Market Sales By Geography (USD MN)
• Medical Device Companies Market Sales By Geography (USD MN)
• Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
• Global Recombinant Factor C Assay Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Recombinant Factor C Assay Report
• Market Research Process
• Market Research Methodology
• Global Recombinant Factor C Assay Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Brand
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Brand (USD MN)
• PyroGene (PyroGene Bulk rFC (2,880 tests), PyroGene rFC (192 tests)) Market Sales By Geography (USD MN)
• EndoNext (EndoZyme II, EndoZyme II GO, EndoLisa) Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Biotechnology Companies Market Sales By Geography (USD MN)
• Medical Device Companies Market Sales By Geography (USD MN)
• Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.